Company intelligence / Profile preview

BioQuest Technologies

Seoul, Seoul, South Korea

Ownership: Private
Development stage: Other

Overview

BioQuest is a South Korean biotechnology company dedicated to the development of innovative microbiome-based therapeutics and diagnostics. Utilizing its proprietary MQ-Platform, the company identifies and optimizes live biotherapeutic products (LBPs) that modulate the gut microbiome to treat metabolic, inflammatory, and autoimmune conditions. BioQuest's pipeline features several pre-clinical programs targeting high-prevalence indications such as obesity, type 2 diabetes, and NASH. The company aims to bridge the gap between microbiome research and clinical application through its integrated discovery and development engine.

Therapeutic areas: OncologyEndocrinologyDermatologyGastroenterology
Modalities: Live biotherapeutic product therapyMicrobial therapy
Industry: Biotech

Beyond the preview

Go deeper on BioQuest Technologies.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on BioQuest Technologies.

Explore the full profile